movement disorders
movement disorders
Roche’s $50B US Boost: Jobs and Growth Ahead!
BIOT
Roche is investing $50B in U.S. manufacturing and R&D, creating jobs and addressing looming tariffs! 🇺🇸🏭📈 Biopharma Investment
Ipsen’s $18bn Pipeline Expansion Targets Movement Disorders
BIOT
🔬 Ipsen SA and Skyhawk Therapeutics Inc join forces in a groundbreaking $1.8bn deal to treat rare neurological disorders. 💪🧠
